Dai, Yibo
Knisely, Anne
Yano, Mitsutake https://orcid.org/0000-0002-4436-838X
Dang, Minghao https://orcid.org/0000-0001-7287-2877
Hinchcliff, Emily M.
Lee, Sanghoon
Welp, Annalyn https://orcid.org/0000-0001-5888-3342
Chelvanambi, Manoj https://orcid.org/0000-0003-2130-3118
Lastrapes, Matthew https://orcid.org/0000-0003-0780-3466
Liu, Heng
Yuan, Zhe
Wang, Chen
Nie, Hao
Jean, Stephanie
Montaner, Luis J. https://orcid.org/0000-0001-5799-6759
Hou, Jiakai https://orcid.org/0000-0003-2875-8756
Patel, Ami
Patel, Shrina
Fellman, Bryan
Yuan, Ying
Sun, Baohua
Pandurengan, Renganayaki Krishna
Cuentas, Edwin Roger Parra
Celestino, Joseph
Liu, Yan
Liu, Jinsong https://orcid.org/0000-0002-3239-6658
Hillman, R. Tyler https://orcid.org/0000-0002-9832-9925
Westin, Shannon N. https://orcid.org/0000-0002-1922-0156
Sood, Anil K. https://orcid.org/0000-0003-4242-1762
Soliman, Pamela T.
Shafer, Aaron
Meyer, Larissa A.
Gershenson, David M.
Vining, David
Ganeshan, Dhakshinamoorthy
Lu, Karen
Wargo, Jennifer A. https://orcid.org/0000-0003-3438-7576
Peng, Weiyi https://orcid.org/0000-0002-7785-6240
Zhang, Rugang https://orcid.org/0000-0002-7255-2360
Wang, Linghua https://orcid.org/0000-0001-9380-0266
Jazaeri, Amir A. https://orcid.org/0000-0003-4335-4151
Article History
Received: 13 November 2021
Accepted: 27 May 2025
First Online: 2 July 2025
Competing interests
: A.K.S. reports a consulting role at Merck, Onxeo, ImmunoGen, GSK, Astra Zeneca and Iylon. The other authors declare no competing interests.